FDA Inspection 1014539 — Giorgi Dzagnidze, M.D.
The FDA completed an inspection of Giorgi Dzagnidze, M.D. on April 28, 2017 in Tbilisi. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 28, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tbilisi (Georgia)
Additional Details
Clinical Investigator (CI)